These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 33684601)

  • 21. Construction of early risk prediction models for bronchopulmonary dysplasia in preterm infants.
    Zhang R; Xu FL; Li WL; Qin FY; Jin XY; Zhang Y; Zhang C; Zhu C
    Zhongguo Dang Dai Er Ke Za Zhi; 2021 Oct; 23(10):994-1001. PubMed ID: 34719413
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bronchopulmonary dysplasia in very preterm infants: Outcome up to preschool age, in a single center of Austria.
    Reiterer F; Scheuchenegger A; Resch B; Maurer-Fellbaum U; Avian A; Urlesberger B
    Pediatr Int; 2019 Apr; 61(4):381-387. PubMed ID: 30793436
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Clinical characteristics and risk factors of very low birth weight and extremely low birth weight infants with bronchopulmonary dysplasia: multicenter retrospective analysis].
    Jiangsu Multicenter Study Collaborative Group for Breastmilk Feeding in Neonatal Intensive Care Units
    Zhonghua Er Ke Za Zhi; 2019 Jan; 57(1):33-39. PubMed ID: 30630229
    [No Abstract]   [Full Text] [Related]  

  • 24. Urinary leukotriene E(4) excretion during the first month of life and subsequent bronchopulmonary dysplasia in premature infants.
    Sheikh S; Null D; Gentile D; Bimle C; Skoner D; McCoy K; Guthrie R
    Chest; 2001 Jun; 119(6):1749-54. PubMed ID: 11399701
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Morbidity and respiratory outcomes in infants requiring tracheostomy for severe bronchopulmonary dysplasia.
    House M; Nathan A; Bhuiyan MAN; Ahlfeld SK
    Pediatr Pulmonol; 2021 Aug; 56(8):2589-2596. PubMed ID: 34002957
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Changes of serum interleukin-33 in preterm infants with bronchopulmonary dysplasia].
    Chen JL; Zhang CL
    Zhongguo Dang Dai Er Ke Za Zhi; 2020 Jul; 22(7):716-720. PubMed ID: 32669167
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Invasive mechanical ventilation and biomarkers as predictors of bronchopulmonary dysplasia in preterm infants.
    Nascimento CP; Maia LP; Alves PT; Paula AT; Cunha Junior JP; Abdallah VOS; Ferreira DMLM; Goulart LR; Azevedo VMGO
    J Pediatr (Rio J); 2021; 97(3):280-286. PubMed ID: 32407675
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of Chorioamnionitis With Bronchopulmonary Dysplasia Among Preterm Infants: A Systematic Review, Meta-analysis, and Metaregression.
    Villamor-Martinez E; Álvarez-Fuente M; Ghazi AMT; Degraeuwe P; Zimmermann LJI; Kramer BW; Villamor E
    JAMA Netw Open; 2019 Nov; 2(11):e1914611. PubMed ID: 31693123
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relationship between clinical severity of "new" bronchopulmonary dysplasia and HRCT abnormalities in VLBW infants.
    Sung TJ; Hwang SM; Kim MY; Park SG; Choi KY
    Pediatr Pulmonol; 2018 Oct; 53(10):1391-1398. PubMed ID: 29979483
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of sildenafil on evolving bronchopulmonary dysplasia in extremely preterm infants: a randomised controlled pilot study.
    König K; Barfield CP; Guy KJ; Drew SM; Andersen CC
    J Matern Fetal Neonatal Med; 2014 Mar; 27(5):439-44. PubMed ID: 23796045
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Respiratory burst activity in bronchopulmonary dysplasia and changes with dexamethasone.
    Ballabh P; Simm M; Kumari J; Califano C; Aghai Z; Laborada G; Sison C; Cunningham-Rundles S
    Pediatr Pulmonol; 2003 May; 35(5):392-9. PubMed ID: 12687597
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Late (≥ 7 days) inhalation corticosteroids to reduce bronchopulmonary dysplasia in preterm infants.
    Onland W; Offringa M; van Kaam A
    Cochrane Database Syst Rev; 2012 Apr; (4):CD002311. PubMed ID: 22513906
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The association between clinical and biochemical characteristics of late-onset sepsis and bronchopulmonary dysplasia in preterm infants.
    Ebrahimi ME; Romijn M; Vliegenthart RJS; Visser DH; van Kaam AH; Onland W
    Eur J Pediatr; 2021 Jul; 180(7):2147-2154. PubMed ID: 33629121
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of Inhaled Nitric Oxide on Survival Without Bronchopulmonary Dysplasia in Preterm Infants: A Randomized Clinical Trial.
    Hasan SU; Potenziano J; Konduri GG; Perez JA; Van Meurs KP; Walker MW; Yoder BA;
    JAMA Pediatr; 2017 Nov; 171(11):1081-1089. PubMed ID: 28973344
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Impact of Postnatal Systemic Steroids on the Growth of Preterm Infants: A Multicenter Cohort Study.
    Zozaya C; Avila-Alvarez A; García-Muñoz Rodrigo F; Couce ML; Arruza L; Fernandez-Perez C; Castro A; Cuesta MT; Vacas B; Vento M; Saenz de Pipaón M
    Nutrients; 2019 Nov; 11(11):. PubMed ID: 31717933
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Duration of mechanical ventilation and prediction of bronchopulmonary dysplasia and home oxygen in extremely preterm infants.
    Dassios T; Williams EE; Hickey A; Greenough A
    Acta Paediatr; 2021 Jul; 110(7):2052-2058. PubMed ID: 33555069
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of melatonin efficacy in prevention of bronchopulmonary dysplasia in preterm newborn infants.
    Gharehbaghi MM; Yeganedoust S; Shaseb E; Fekri M
    Turk J Pediatr; 2022; 64(1):79-84. PubMed ID: 35286033
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ventilation and respiratory outcome in extremely preterm infants: trends in the new millennium.
    Regin Y; Gie A; Eerdekens A; Toelen J; Debeer A
    Eur J Pediatr; 2022 May; 181(5):1899-1907. PubMed ID: 35034202
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Late Surfactant Administration in Very Preterm Neonates With Prolonged Respiratory Distress and Pulmonary Outcome at 1 Year of Age: A Randomized Clinical Trial.
    Hascoët JM; Picaud JC; Ligi I; Blanc T; Moreau F; Pinturier MF; Zupan V; Guilhoto I; Hamon IR; Alexandre C; Bouissou A; Storme L; Patkai J; Pomedio M; Rouabah M; Coletto L; Vieux R
    JAMA Pediatr; 2016 Apr; 170(4):365-72. PubMed ID: 26928567
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The use of postnatal corticosteroid therapy in premature infants to prevent or treat bronchopulmonary dysplasia: current situation and recommendations].
    Jarreau PH; Fayon M; Baud O; Autret-Leca E; Danan M; de Verdelhan A; Castot A
    Arch Pediatr; 2010 Oct; 17(10):1480-7. PubMed ID: 20864322
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.